Tsukamoto Tetsuo, Takeda Akiko, Yamamoto Takuya, Yamamoto Hiroyuki, Kawada Miki, Matano Tetsuro
International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Japan.
J Virol. 2009 Sep;83(18):9339-46. doi: 10.1128/JVI.01120-09. Epub 2009 Jul 8.
Despite many efforts to develop AIDS vaccines eliciting virus-specific T-cell responses, whether induction of these memory T cells by vaccination before human immunodeficiency virus (HIV) exposure can actually contribute to effective T-cell responses postinfection remains unclear. In particular, induction of HIV-specific memory CD4(+) T cells may increase the target cell pool for HIV infection because the virus preferentially infects HIV-specific CD4(+) T cells. However, virus-specific CD4(+) helper T-cell responses are thought to be important for functional CD8(+) cytotoxic-T-lymphocyte (CTL) induction in HIV infection, and it has remained unknown whether HIV-specific memory CD8(+) T cells induced by vaccination without HIV-specific CD4(+) T-cell help can exert effective responses after virus exposure. Here we show the impact of CD8(+) T-cell memory induction without virus-specific CD4(+) T-cell help on the control of a simian immunodeficiency virus (SIV) challenge in rhesus macaques. We developed a prophylactic vaccine by using a Sendai virus (SeV) vector expressing a single SIV Gag(241-249) CTL epitope fused with enhanced green fluorescent protein (EGFP). Vaccination resulted in induction of SeV-EGFP-specific CD4(+) T-cell and Gag(241-249)-specific CD8(+) T-cell responses. After a SIV challenge, the vaccinees showed dominant Gag(241-249)-specific CD8(+) T-cell responses with higher effector memory frequencies in the acute phase and exhibited significantly reduced viral loads. These results demonstrate that virus-specific memory CD8(+) T cells induced by vaccination without virus-specific CD4(+) T-cell help could indeed facilitate SIV control after virus exposure, indicating the benefit of prophylactic vaccination eliciting virus-specific CTL memory with non-virus-specific CD4(+) T-cell responses for HIV control.
尽管人们为研发能引发病毒特异性T细胞反应的艾滋病疫苗付出了诸多努力,但在人体免疫缺陷病毒(HIV)暴露前通过接种疫苗诱导产生的这些记忆T细胞是否真的有助于感染后有效的T细胞反应,仍不明确。特别是,HIV特异性记忆CD4(+) T细胞的诱导可能会增加HIV感染的靶细胞库,因为该病毒优先感染HIV特异性CD4(+) T细胞。然而,病毒特异性CD4(+)辅助性T细胞反应被认为对HIV感染中功能性CD8(+)细胞毒性T淋巴细胞(CTL)的诱导很重要,而在没有HIV特异性CD4(+) T细胞帮助的情况下,通过接种疫苗诱导产生的HIV特异性记忆CD8(+) T细胞在病毒暴露后能否发挥有效反应,一直未知。在此,我们展示了在没有病毒特异性CD4(+) T细胞帮助的情况下诱导CD8(+) T细胞记忆对恒河猴感染猴免疫缺陷病毒(SIV)的控制作用。我们通过使用表达与增强型绿色荧光蛋白(EGFP)融合的单个SIV Gag(241 - 249) CTL表位的仙台病毒(SeV)载体,研发了一种预防性疫苗。接种疫苗导致了SeV - EGFP特异性CD4(+) T细胞和Gag(241 - 249)特异性CD8(+) T细胞反应的诱导。在SIV攻击后,接种疫苗的动物在急性期表现出占主导地位的Gag(241 - 249)特异性CD8(+) T细胞反应,效应记忆频率更高,并且病毒载量显著降低。这些结果表明,在没有病毒特异性CD4(+) T细胞帮助的情况下通过接种疫苗诱导产生的病毒特异性记忆CD8(+) T细胞确实能够在病毒暴露后促进SIV的控制,这表明预防性接种疫苗引发病毒特异性CTL记忆并伴有非病毒特异性CD4(+) T细胞反应对控制HIV具有益处。